<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.e-jmii.com//inpress?rss=yes"><title>Journal of Microbiology, Immunology and Infection - Articles in Press</title><description>Journal of Microbiology, Immunology and Infection RSS feed: Articles in Press.    The  Journal of Microbiology, Immunology and Infection  is currently an official bi-monthly publication of the Taiwan Society 
of Microbiology, the Chinese Society of Immunology, the Infectious Diseases Society of Taiwan and the Taiwan Society
of Parasitology. 
The Journal is committed to disseminate high quality research related to latest trends and advanced in microbiology, immunology, and 
infectious diseases. Manuscript categories included original articles, review articles, case reports,
brief communications, and research 
notes.   </description><link>http://www.e-jmii.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2011 Published by Elsevier Inc.  </dc:rights><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:issn>1684-1182</prism:issn><prism:publicationDate>2012-02-06</prism:publicationDate><prism:copyright> © 2011 Published by Elsevier Inc.  </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002398/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001630/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002647/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002702/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002520/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002544/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002623/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002660/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002349/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002386/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002313/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002556/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001824/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002350/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001605/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211002325/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001599/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001629/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001654/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS168411821100171X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001800/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001812/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001836/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS168411821100185X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001563/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001642/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS168411821100168X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001691/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001708/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001721/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001666/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001848/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211001368/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000028/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS168411821100003X/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000041/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000053/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000065/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000077/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000089/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000090/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000119/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000120/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000132/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000144/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000156/abstract?rss=yes"/><rdf:li rdf:resource="http://www.e-jmii.com/article/PIIS1684118211000107/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002398/abstract?rss=yes"><title>Study of the cultivable microflora of the large intestine of the rat under varied environmental hyperbaric pressures - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002398/abstract?rss=yes</link><description>Background/Purpose(s): We conducted an in vivo experiment to investigate the effect of hyperbarometric air pressure on the quantity and composition of the cultivable microflora of the large intestine.Methods: Using selective culture-based methods, we enumerated from the large intestine total aerobes and total anaerobes, and indicator bacteria such as Escherichia coli, other Enterobacteriaceae, Bifidobacterium spp., Lactobacillus spp. and Clostridium perfringens, and studied their quantitative variation.Results: Total aerobes and facultative anaerobes (E. coli and other Enterobacteriaceae) were increased with an increase in air pressure, whereas the increase caused a drastic reduction in the numbers of total anaerobes and Clostridium perfringens. Bifidobacterium spp. and Lactobacillus spp. were affected slightly by the altered air pressures. Variation in the numbers of these groups of bacteria was correlated to dose and duration of hyperbaric treatment.Conclusion: We conclude from our results that air pressure is an important exogenous factor that strongly modulates bacterial colonization of the large intestine and the composition of the intestinal microflora, and that the occurrence of gastrointestinal disorders during hyperbarism is a result of alteration in the indigenous microflora.</description><dc:title>Study of the cultivable microflora of the large intestine of the rat under varied environmental hyperbaric pressures - Corrected Proof</dc:title><dc:creator>Chiranjit Maity, Atanu Adak, Tarun Kumar Pathak, Bikas Ranjan Pati, Keshab Chandra Mondal</dc:creator><dc:identifier>10.1016/j.jmii.2011.12.002</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2012)</dc:source><dc:date>2012-02-06</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2012-02-06</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001630/abstract?rss=yes"><title>Fulminant Aeromonas hydrophila infection during acute lymphoblastic leukemia treatment - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001630/abstract?rss=yes</link><description>Aeromonas hydrophila septicemia has a fulminant course and it has been usually reported in immunocompromised hosts and rarely among children with leukemia. High morbidity and mortality is associated with A hydrophila infections. We describe the case of a child with acute lymphoblastic leukemia who presented with septicemia due to A hydrophila. The patient presented with fever and skin discoloration during a febrile neutropenia episode, which rapidly evolved into bacteremia and extensive thigh suppuration, fasciitis, and myonecrosis. Apart from antibiotic treatment, surgical debridement to relieve compartment pressure and prevent further lower extremity compromise was promptly performed. Despite long delays in chemotherapy and an extensive tissue gap, primary closure of the involved area was possible with full cosmetic and functional limb recovery, and the patient has remained in clinical remission for more than 7 years.</description><dc:title>Fulminant Aeromonas hydrophila infection during acute lymphoblastic leukemia treatment - Corrected Proof</dc:title><dc:creator>Vassilios Papadakis, Nikolaos Poniros, Karerina Katsibardi, Athina-Eleni Charissiadou, John Anastasopoulos, Sophia Polychronopoulou</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.008</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2012)</dc:source><dc:date>2012-01-24</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2012-01-24</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002647/abstract?rss=yes"><title>Comparison of cryoglobulinemia in children and adults - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002647/abstract?rss=yes</link><description>Background: Cryoglobulinemic vasculitis is a systemic vasculitis resulting from circulating immune complex deposition in the small vessels and is characterized by variable clinical features, including purpura, Raynaud’s syndrome, ulcerations, arthralgia, glomerulonephritis, and peripheral neuropathy. Cryoglobulinemia can also result from hepatitis C virus (HCV) infection. The clinical spectrum and associated or underlying diseases of cryoglobulinemia in different age groups is not well understood. This study investigated the demographic, clinical, serologic features, and associated or underlying diseases in children and adult patients with cryoglobulinemia.Methods: The retrospective study included 114 patients (18 children, 96 adults) who presented with cryoglobulinemia between 2000 and 2010 at the Chang Gung Memorial Hospital. Their medical records were reviewed and serological and virologic assessments were analyzed.Results: In this group of patients, children had a significantly higher prevalence of prolonged fever (16.7% vs. 3.13%; p=0.018), arthralgia (66.67% vs. 16.67%; p&lt;0.001), arthritis (66.67% vs. 15.63%; p&lt;0.001) and cutaneous involvement (77.78% vs. 50%; p=0.03) compared with adults. Both the adult and children groups had a greater frequency of hepatitis B virus (HBV) infection (20.8% and 5.6%, respectively), than HCV infection (12.5% and 0%, respectively).Conclusions: Children with cryoglobulinemia had a significantly higher prevalence of prolonged fever, arthralgia, arthritis and cutaneous involvement compared with adults.</description><dc:title>Comparison of cryoglobulinemia in children and adults - Corrected Proof</dc:title><dc:creator>Yu-Ting Liou, Jing-Long Huang, Liang-Shiou Ou, Yu-Hsuan Lin, Kuang-Hui Yu, Shue-Fen Luo, Huei-Huang Ho, Lieh-Bang Liou, Kuo-Wei Yeh</dc:creator><dc:identifier>10.1016/j.jmii.2011.12.027</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2012)</dc:source><dc:date>2012-01-11</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2012-01-11</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002702/abstract?rss=yes"><title>Mycobacterium avium complex infection-related immune reconstitution inflammatory syndrome of the central nervous system in an HIV-infected patient: Case report and review - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002702/abstract?rss=yes</link><description>Disseminated Mycobacterium avium complex (MAC) infection involves the central nervous system (CNS) less frequently than tuberculosis, and MAC-related immune reconstitution inflammatory syndrome (IRIS) of the CNS in AIDS patients is even more rarely described. We report a case of MAC-related IRIS of the CNS in an HIV-infected patient who presented with meningoencephalitis and myelitis 2 months after discontinuation of antiMAC therapy, when he had achieved prolonged suppression of HIV replication and restoration of CD4 counts to &gt;100 cells/μL for 1 year. Cases of MAC-related IRIS of the CNS reported in the literature are reviewed.</description><dc:title>Mycobacterium avium complex infection-related immune reconstitution inflammatory syndrome of the central nervous system in an HIV-infected patient: Case report and review - Corrected Proof</dc:title><dc:creator>Yi-Chien Lee, Ching-Lan Lu, Chung-Chih Lai, Yu-Tzu Tseng, Hsin-Yun Sun, Chien-Ching Hung</dc:creator><dc:identifier>10.1016/j.jmii.2011.12.033</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2012)</dc:source><dc:date>2012-01-09</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2012-01-09</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002520/abstract?rss=yes"><title>Non-typhoidal Salmonella bacteremia among adults: An adverse prognosis in patients with malignancy - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002520/abstract?rss=yes</link><description>Background: Clinical information about non-typhoidal Salmonella (NTS) bacteremia in patients with malignancy has rarely been described. This study investigated clinical characteristics and prognostic variables of patients with malignancy while complicated with NTS bacteremia.Methods: The study included demographic data, clinical information, and outcome in adults (≥18 years old) with and without malignancy complicated with NTS bacteremia at a medical center from 2000 to 2009.Results: There were 206 patients with NTS bacteremia. The serogroups of NTS isolates included group B (40.2%), group D (30.9%), group C (26.5%), and group E (1.5%). Extraintestinal infections were noted in 66 (32.4%) patients and were mainly endovascular (26/206, 12.7%) or pleuropulmonary (17/206, 8.3%) infections. On multivariate analysis, independent factors for in-hospital mortality included shock (odds ratio [OR] 9.13; 95% confidence interval [CI] 3.81–21.83; p &lt; 0.001), malignancy (OR 8.42; 95% CI 3.12–22.71; p &lt; 0.001), and acute renal failure (OR 2.63; 95% CI 1.11–6.22; p = 0.028). Different clinical presentations and outcome were noted in 74 (36.2%) patients with malignancy and 130 without malignancy. The former had more leucopenia and thrombocytopenia at initial presentation and fewer extraintestinal infections (20.2% vs. 39.2%, p = 0.005), endovascular infections (2.7% vs. 18.5%; p = 0.002), and serovar Choleraesuis (10.8% vs. 27.7%; p = 0.005). An elevated in-hospital mortality rate was noted in patients with malignancy compared to those without malignancy (40.5% vs. 17.7%, p &lt; 0.001). Among patients with malignancy, multivariate analysis revealed that shock was the only independent factor associated with in-hospital mortality (OR 7.52; 95% CI, 2.38–23.80; p = 0.001).Conclusion: Malignancy is an adverse prognostic factor in patients with NTS bacteremia. Food safety in patients with malignancy should be emphasized to prevent salmonellosis.</description><dc:title>Non-typhoidal Salmonella bacteremia among adults: An adverse prognosis in patients with malignancy - Corrected Proof</dc:title><dc:creator>Chia-Wen Li, Po-Lin Chen, Nan-Yao Lee, Hsin-Chun Lee, Chia-Ming Chang, Ching-Chi Lee, Wen-Chien Ko</dc:creator><dc:identifier>10.1016/j.jmii.2011.12.015</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2012)</dc:source><dc:date>2012-01-03</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2012-01-03</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002544/abstract?rss=yes"><title>Astrovirus gastroenteritis in hospitalized children of less than 5 years of age in Taiwan, 2009 - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002544/abstract?rss=yes</link><description>Background/Purpose: Acute gastroenteritis is a common illness in children under 5 years old. Although rotavirus is a leading cause, other viruses including astrovirus are also important, but have been the subject of limited studies. This is a prospective study to investigate astrovirus gastroenteritis in hospitalized children in Taiwan.Material/Method: From January 2009 to December 2009, children below 5 years of age admitted to three hospitals in Taiwan due to acute gastroenteritis were eligible for this study. Stool specimens were sent for the detection of astrovirus by reverse transcriptase polymerase chain reaction; once positive for astrovirus, the sequencing and phylogenetic analysis of each strain was performed.Results: A total of 989 children were enrolled during the study period. The overall positive rate of astrovirus was 1.6%, ranging from 1.03% to 2.26% in different hospitals, while rotavirus accounted for 20.2% of the patients. Six of the 16 children (37.5%) with astroviral infection had documented coinfection with rotavirus. The median age of infection was 28.2 months. The seasonal distribution of astrovirus peaked from April to June. Diarrhea alone (40% vs. 2.1%, p &lt; 0.0001) was significantly more commonly seen than the triad of fever, vomiting and diarrhea (30% vs. 71%, p = 0.0062) in children with astroviral infection alone than in those with rotaviral infection alone. The mean duration of diarrhea was significantly longer in patients with mixed infection than those with astroviral infection alone (6.8 vs. 4.2 days, p = 0.013). Respiratory symptoms were noted in 10 children (62.5%). Serotype HAstV-1 was the most common (68.8%).Conclusion: Astrovirus accounted for 1.6% of infections in children under 5 years hospitalized with acute gastroenteritis in Taiwan. Compared with those caused by rotavirus, the incidence of gastroenteritis in hospitalized children caused by astrovirus was low and the disease severity was mild.</description><dc:title>Astrovirus gastroenteritis in hospitalized children of less than 5 years of age in Taiwan, 2009 - Corrected Proof</dc:title><dc:creator>Wei-Chen Tseng, Fang-Tzy Wu, Chao A. Hsiung, Wan-Chi Chang, Ho-Sheng Wu, Ching-Yi Wu, Jen-Shiou Lin, Shun-Cheng Yang, Kao-Pin Hwang, Yhu-Chering Huang</dc:creator><dc:identifier>10.1016/j.jmii.2011.12.017</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2012)</dc:source><dc:date>2012-01-03</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2012-01-03</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002623/abstract?rss=yes"><title>Antimicrobial susceptibility of Gram-positive cocci isolated from patients with conjunctivitis and keratitis in Crete, Greece - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002623/abstract?rss=yes</link><description>Purpose: To assess the in vitro susceptibility of Streptococcus pneumoniae, Staphylococcus aureus and coagulase-negative staphylococci (CoNS) ocular isolates to antibiotics, and identify changing trends in resistance over a 10-year period.Methods: All isolates from ocular infections collected between 2000 and 2009 were prospectively tested against several antibiotics in vitro. S. pneumoniae isolates (n = 93) were tested against 20 and S. aureus (n = 120) and CoNS (n = 214) against 19 antibiotics. To identify changes in susceptibility patterns, we compared results from 2000–2004 with those from 2005–2009. We also compared the antibiotic susceptibilities against aminoglycosides and quinolones between methicillin-resistant S. aureus (MRSA) and methicillin-susceptible S. aureus (MSSA) isolates.Results: All S. pneumoniae isolates were susceptible to quinolones, and 99% were susceptible to chloramphenicol. Regarding S. aureus, we noted a significant increase in resistance against penicillin in recent years (p = 0.016). Over 90% of S. aureus isolates were susceptible to quinolones and aminoglycosides. MRSA isolates were more resistant to ciprofloxacin and ofloxacin than MSSA isolates were (p = 0.016). Concerning CoNS, a significant increase in susceptibility to amikacin was noted in the second study period (p = 0.01).Conclusion: Quinolones remain an excellent treatment option for bacterial conjunctivitis and keratitis due to Gram-positive cocci in our region.</description><dc:title>Antimicrobial susceptibility of Gram-positive cocci isolated from patients with conjunctivitis and keratitis in Crete, Greece - Corrected Proof</dc:title><dc:creator>Elpis Mantadakis, Sofia Maraki, Lambros Michailidis, Zoe Gitti, Ioannis G. Pallikaris, George Samonis</dc:creator><dc:identifier>10.1016/j.jmii.2011.12.025</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2012)</dc:source><dc:date>2012-01-03</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2012-01-03</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002660/abstract?rss=yes"><title>Reduction of Salmonella enterica serovar Choleraesuis carrying large virulence plasmids after the foot and mouth disease outbreak in swine in southern Taiwan, and their independent evolution in human and pig - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002660/abstract?rss=yes</link><description>Background/Purpose: Salmonella enterica serovar Choleraesuis (S. Choleraesuis) is a highly invasive zoonotic pathogen that causes bacteremia in humans and pigs. The prevalence of S. Choleraesuis in man has gradually decreased since the outbreak of foot and mouth disease in pigs in 1997 in southern Taiwan. The goal of this study was to investigate the change in prevalence of S. Choleraesuis carrying the virulence plasmid (pSCV) in human and swine isolates collected in 1995–2005 and characterize these.Methods: 380 isolates were collected from human and swine blood samples. Large pSCVs were determined by PCR and Southern blot analysis. Antimicrobial susceptibility and resistance genes, and the phylogenetic association of these large pSCV were analyzed.Results: The number of isolates harboring the large pSCV was significantly reduced, and their prevalence differed between human and swine isolates. These large pSCVs were a recombinant of original 50-kb pSCV and R plasmid. In addition, some large pSCVs lacked two pSCV-specific deletion regions from pef to repC and from traT to samA. These large pSCVs carried the resistance genes blaTEM, aadA2, and sulI, as well as class I integrons of 0.65 and/or 1.9 kb in size, but were inconjugatible. Phylogenetic analysis demonstrated that the large pSCV evolves independently in human and swine isolates.Conclusion: S. Choleraesuis with large pSCV was significantly reduced after the foot and mouth disease outbreak and may evolve in human and swine specific isolates.</description><dc:title>Reduction of Salmonella enterica serovar Choleraesuis carrying large virulence plasmids after the foot and mouth disease outbreak in swine in southern Taiwan, and their independent evolution in human and pig - Corrected Proof</dc:title><dc:creator>Jann-Inn Tzeng, Chi-Hong Chu, Shu-Wun Chen, Chia-Ming Yeh, Chern-Hsun Chiu, Chien-Shun Chiou, Jiunn-Horng Lin, Chishih Chu</dc:creator><dc:identifier>10.1016/j.jmii.2011.12.029</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2012)</dc:source><dc:date>2012-01-03</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2012-01-03</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002349/abstract?rss=yes"><title>Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002349/abstract?rss=yes</link><description>Background/Purpose: A growing number of β-lactamases have been reported in Pseudomonas aeruginosa isolates. The aims of this study were to survey the types of extended-spectrum β-lactamases (ESBLs) by polymerase chain reaction (PCR), to evaluate the reliability of phenotypic tests for ESBLs, and to identify the clonal distribution by pulsed-field gel electrophoresis (PFGE) among P. aeruginosa isolates resistant to expanded-spectrum cephalosporins (ceftazidime, aztreonam, or cefepime).Methods: The antimicrobial susceptibility of 57 P. aeruginosa isolates from blood specimens were examined according to the recommendations of the Clinical Laboratory Standards Institute. ESBL phenotypes were determined by using cloxacillin-containing double disc synergy test (DDST). The existence of 11 β-lactamase genes was detected by PCR.Results: Of the 57 P. aeruginosa isolates, 35 (61.4%) isolates were PCR-positive for β-lactamase genes. Twelve of 35 isolates were PCR-positive for combination of ampC and ESBL genes, including TEM, GES, SHV, VEB and OXA-I genes. The sensitivity and specificity of cloxacillin-containing DDST (using the criteria of ceftazidime zone diameter increased ≧5 mm) were 84.1% and 54.5%, respectively. Nine clusters were classified among 35 PCR-positive isolates by PFGE. Isolates of clusters B and C were distributed in different wards of this hospital during a period of 3–4 years.Conclusion: ESBL genes are not uncommon in P. aeruginosa isolates. Cloxacillin-containing DDST can enhance the sensitivity and has a potential role for phenotypic detection of ESBL-producing P. aeruginosa, and PCR is also helpful for the identification of specific β-lactamase genes. These P. aeruginosa isolates were classified into several diverse clones which could continue to spread in the hospital over a long period of time.</description><dc:title>Phenotypic detection and polymerase chain reaction screening of extended-spectrum β-lactamases produced by Pseudomonas aeruginosa isolates - Corrected Proof</dc:title><dc:creator>Shih-Ping Lin, Meei-Fang Liu, Chin-Fu Lin, Zhi-Yuan Shi</dc:creator><dc:identifier>10.1016/j.jmii.2011.11.015</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-30</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-30</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002386/abstract?rss=yes"><title>Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002386/abstract?rss=yes</link><description>Background/Purpose: The incidence of Clostridium difficile-associated diarrhea (CDAD) is increasing worldwide. Spread of an epidemic hypervirulent strain in southern Taiwan was associated with poor outcome. This prospective study evaluates the incidence and clinical manifestation of CDAD following a hospital-wide hand hygiene promotion program in a 2,200-bed teaching hospital in northern Taiwan.Patients and Methods: From June 1, 2010 to October 31, 2010, a predefined protocol was used to actively survey CDAD at 11 high-risk units. Stool samples of patients with antibiotic-associated diarrhea (AAD) were submitted for stool culture and toxin A/B assay using a combined enzyme immunoassay. CDAD was diagnosed by a positive toxin assay.Results: The incidence of CDAD was 0.45/1000 patient-days and was highest in medical intensive care units (7.9/1000 patient-days), followed by hemato-oncology wards, and infectious disease wards. Occurrence of CDAD was associated with ≥3 stool pus cells per high power field (p = 0.018), prior use of metronidazole (p = 0.029), high usage of beta-lactamase stable penicillins (p = 0.046), and anaerobe-active antibiotics (p = 0.029). No attributable mortality was found. The incidence of CDAD was lower than that previously observed (1.0/1000 patient-days in 2003, p &lt; 0.001).Conclusion: This study showed a lower incidence of CDAD and absence of attributable mortality. The impact of hand hygiene promotion and other infection control measures on decreasing incidence of CDAD warrants further elucidation.</description><dc:title>Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan - Corrected Proof</dc:title><dc:creator>Yi-Chieh Lee, Jann-Tay Wang, An-Chi Chen, Wang-Huei Sheng, Shan-Chwen Chang, Yee-Chun Chen</dc:creator><dc:identifier>10.1016/j.jmii.2011.12.001</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-30</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-30</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002313/abstract?rss=yes"><title>Development of an antigen-capture enzyme-linked immunosorbent assay using monoclonal antibodies for detecting H6 avian influenza viruses - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002313/abstract?rss=yes</link><description>The H6 subtype of avian influenza virus (AIV) infection occurs frequently in wild and domestic birds. AIV antigen detection is preferred for controlling AIV as birds are infected before they produce antibodies. The purpose of this study was to develop an early diagnostic method for AIV detection. Six monoclonal antibodies (mAbs) developed from a field H6N1 AIV strain were tested for their ability to bind to viruses. The two that showed the greatest binding ability to AIVs were used for antigen detection. An antigen-capture enzyme-linked immunosorbent assay (ELISA) to detect H6 AIVs was developed using these mAbs. One mAb was coated onto an ELISA plate as the capture antibody. The other mAb was used as the detector antibody after labeling with horseradish peroxidase. The antigen-capture ELISA detected H6N1 AIVs but not H5 AIVs, human H1N1, H3N2 influenza or other viruses. This antigen-capture ELISA could be used to specifically detect H6N1 AIV.</description><dc:title>Development of an antigen-capture enzyme-linked immunosorbent assay using monoclonal antibodies for detecting H6 avian influenza viruses - Corrected Proof</dc:title><dc:creator>Yi-Tung Chen, Zak Tsao, Shu-Ting Chang, Ron-Huay Juang, Lih-Chiann Wang, Chung-Ming Chang, Ching-Ho Wang</dc:creator><dc:identifier>10.1016/j.jmii.2011.11.012</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-29</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-29</prism:publicationDate><prism:section>BRIEF COMMUNICATION</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002556/abstract?rss=yes"><title>Characterization of subtypes of the influenza A hemagglutinin (HA) gene using profile hidden Markov models - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002556/abstract?rss=yes</link><description>Background: The influenza A virus has evolved into 16 hemagglutinin (HA) subtypes with different antigenic properties. Thus far typing has been primarily assay based, but the many sequences available from the US National Center for Biotechnology Information (NCBI) offer alternative ways of characterizing the HA gene.Methods: All available HA sequences from the NCBI were analyzed. The software package HMMER was used to score how a training sequence fitted a profile hidden Markov model (profile HMM) constructed from the consensus sequence of one particular HA subtype, Hx, where x=1 to 16. Scores from sequences of the same subtype and from other subtypes were then compared to see if they were separable. This approach was implemented in a stepwise manner, utilizing a sliding window of 100 amino acids with 10-amino-acid increments to build many subtype-specific models, and then assessing which 100-amino acid segments yielded the desired differentiability.Results: Segment-based analysis revealed domains that correlate to HA sequence heterogeneity from one subtype to the others. For example, we showed that H1 segments covering only the second half of HA are not statistically separable from H2, H5 and H6 within the same region, suggesting evolutionary relatedness for these subtypes. The HA1 domain was found to be mostly differentiable between subtypes, which is in line with wet-lab findings that the domain is antigenicity-rich. We also reported a couple of regions that can be conveniently used to characterize all HA subtypes.Conclusion: We established an analysis framework for assessing sequence-subtype association to provide insights into HA subtypes with close evolutionary relationships.</description><dc:title>Characterization of subtypes of the influenza A hemagglutinin (HA) gene using profile hidden Markov models - Corrected Proof</dc:title><dc:creator>Yu-Nong Gong, Guang-Wu Chen, Shin-Ru Shih</dc:creator><dc:identifier>10.1016/j.jmii.2011.12.018</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-26</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-26</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001824/abstract?rss=yes"><title>Diagnostic capacity of rapid influenza antigen test: Reappraisal with experience from the 2009 H1N1 pandemic - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001824/abstract?rss=yes</link><description>Background: The rapid influenza antigen test (RIAT) has been questioned because of its poor sensitivity. Clinicians are confused as to what diagnostic help it may provide. RIAT was reappraised by other laboratory confirmatory tests for its diagnostic capacity.Methods: Records of RIAT, RT-PCR and virus culture, performed for upper respiratory tract samples during the period from July 2009 to January 2010, were reviewed. The sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of RIAT were evaluated with RT-PCR and virus culture as reference.Results: With either positive RT-PCR or positive virus culture as confirmation of presence of the virus, the overall sensitivity was 44.2% (235/532) and the overall PPV was 91.1% (235/258). With both negative RT-PCR and negative virus culture as confirmation of absence of the virus, the overall specificity was 98.2% (239/264) and the overall NPV was 92.6% (239/258). The PPV reached 96.2% during peak prevalence of infection and the NPV increased to 91.7% with low prevalence. The sensitivity for seasonal H3N2 was 56% (56/100), significantly better than the 39.6%, (156/394) for 2009 pandemic H1N1. Although RIAT positivity correlated to the viral load in samples, a substantial amount of negative RIAT samples had high viral load, with 16.8% (260/1548) of Ct value less than 36 and 8.8% (136/1548) of Ct value less than 31.Conclusion: An algorithm is derived for the fast and inexpensive point-of-care laboratory test RIAT for appropriate application in clinical diagnosis of influenza virus infection. In peak seasons, positive RIAT confirms the diagnosis, with PPV over 96%. In low seasons, negative RIAT sufficiently excludes the diagnosis, with NPV over 91%. The sensitivity of RIAT may vary with different species of the influenza virus. Negative RIAT is not necessarily equal to low viral load in the upper respiratory tract or low infectivity of the patient.</description><dc:title>Diagnostic capacity of rapid influenza antigen test: Reappraisal with experience from the 2009 H1N1 pandemic - Corrected Proof</dc:title><dc:creator>Jeng-How Yang, Po-Yen Huang, Shian-Shen Shie, Chung-Guei Huang, Kuo-Chien Tsao, Ching-Tai Huang</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.027</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-19</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-19</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002350/abstract?rss=yes"><title>A scoring system for predicting results of influenza rapid test in children: A possible model facing overwhelming pandemic infection - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002350/abstract?rss=yes</link><description>Background: The pandemic novel influenza H1N1 (swine) influenza A virus (H1N1v) infection has caused large-scale community infection in Taiwan. Anxiety developed in the general public and physicians faced a huge challenge in many aspects. We conducted this prospective study to develop a scoring system based on the clinical manifestations for predicting the results of influenza rapid testing, as a surrogate of influenza rapid testing, to lower the anxiety and decrease the burden for the test.Methods: From September 1, 2009 to October 5, 2009, pediatric patients who received influenza rapid tests were enrolled, and questionnaires were recorded and analyzed in the first 2 weeks. A further scoring system was conducted to predict the results of influenza rapid tests and validated in the next 3 weeks.Results: Eight hundred and forty-five children were enrolled in our study. In the first phase, data from 506 patients showed that those with age ≥ 5 years, fever ≥ 38°C, contact history of influenza A infection, myalgia, lethargy, sore throat, cough, and headache had a higher risk of positive results (odds ratio: 1.1–2.53). A scoring system was designed, with ≥5 points indicating acceptable sensitivity (69.5%) and specificity (63.6%). Three hundred and thirty-nine patients in the second phase were enrolled to validate the scoring system and the positive and negative predictive values were 52.0% and 73.8%.Conclusion: The emergence of H1N1v infection is not only an important medical issue, but also a socioeconomic problem. Based on easily available clinical information, we develop a scoring system as a preliminary screening tool for the general public and first-line health care providers to evaluate the possibility of influenza virus infection. Although this study was limited by the sensitivity of rapid tests, this type of model may be a surrogate weapon when faced with overwhelming pandemic infection in the future, especially in areas with scarce medical resources.</description><dc:title>A scoring system for predicting results of influenza rapid test in children: A possible model facing overwhelming pandemic infection - Corrected Proof</dc:title><dc:creator>Chien-Yu Lin, Hsin Chi, Hsiang-Yu Lin, Lung Chang, Jen-Yin Hou, Ching-Ting Huang, Hung-Chang Lee, Ming-Ren Chen, Chun-Chih Peng, Daniel Tsung-Ning Huang, Nan-Chang Chiu</dc:creator><dc:identifier>10.1016/j.jmii.2011.11.016</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-19</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-19</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001605/abstract?rss=yes"><title>Lethal toxic encephalopathy due to childhood shigellosis or Ekiri syndrome - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001605/abstract?rss=yes</link><description>Lethal toxic encephalopathy due to shigellosis or Ekiri syndrome is a rare complication of shigellosis with a high fatality rate. Data are very limited on factors that can predict this encephalopathy, so we evaluated clinical and laboratory characteristics for these patients. In this study children with extreme toxicity and convulsions followed by rapid neurological deterioration resulting in brain edema and fatal outcome without sepsis and severe dehydration were selected as having lethal toxic encephalopathy. There were 1295 children with shigellosis during the 10 years of the study. Five children (0.4%) had lethal toxic encephalopathy due to shigellosis. Death occurred following rapid neurological detoriation resulting in brain edema despite intensive treatment. Evidence of brain edema may be a prediction factor for death. Early recognition of encephalopathy and measures to prevent brain edema may improve patient outcome.</description><dc:title>Lethal toxic encephalopathy due to childhood shigellosis or Ekiri syndrome - Corrected Proof</dc:title><dc:creator>Babak Pourakbari, Setareh Mamishi, Leila Kohan, Leila Sedighi, Shima Mahmoudi, Fatemeh Fattahi, Mostafa Teymuri</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.005</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-16</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-16</prism:publicationDate><prism:section>BRIEF COMMUNICATION</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211002325/abstract?rss=yes"><title>Antigenemia and cytokine expression in rotavirus gastroenteritis in children - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211002325/abstract?rss=yes</link><description>Background: Antigenemia is commonly found in children with rotavirus infection, although its clinical significance is undetermined. The aim of this study was to evaluate the association of antigenemia with clinical manifestations and cytokine profiles in children infected by rotavirus.Methods: In total, 68 children hospitalized with rotavirus gastroenteritis were enrolled. Serum samples were collected for detection of antigenemia and viremia. Clinical, laboratory and demographic data were analyzed. Proinflammatory, Th1 and Th2 cytokines were evaluated by bead-based flow cytometry.Results: Antigenemia and viremia were found in 45.6% (n = 31) and 5.9% (n = 4) of the 68 rotavirus-infected children, respectively. The mean age of the antigenemia group was significantly greater than that of the non-antigenemia group (43.5 vs. 27.3 months; p = 0.034). The antigenemia group had a significantly shorter length of hospitalization (4.8 vs. 5.8 days; p = 0.0354) in comparison with the non-antigenemia group, and antigenemia was inversely associated with the length of hospitalization (β = 0.31, p = 0.021). A significantly higher tumor necrosis factor (TNF)-β level was found in the patients with antigenemia than those without (236.7 vs. 29.2 pg/mL, p = 0.026). The severity of disease and the rate of extra-intestinal manifestations did not differ between the groups. Viremia was associated with a higher fever (p = 0.012).Conclusions: Antigenemia was positively correlated with shorter hospital stay in children with rotavirus infection. Enhanced innate and T-cell-mediated immunity evidenced by up-regulation of TNF-β was found in patients with antigenemia.</description><dc:title>Antigenemia and cytokine expression in rotavirus gastroenteritis in children - Corrected Proof</dc:title><dc:creator>Tsung-Han Yu, Chi-Neu Tsai, Ming-Wei Lai, Chien-Chang Chen, Hsun-Chin Chao, Che-Wei Lin, Cheng-Hsun Chiu, Shih-Yen Chen</dc:creator><dc:identifier>10.1016/j.jmii.2011.11.013</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-14</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-14</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001599/abstract?rss=yes"><title>Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001599/abstract?rss=yes</link><description>Background/Purpose: The prevalence of ampicillin-resistant Moraxella catarrhalis has been higher in Taiwan than in other countries, with reports of 97.7% in the 1990s. The aims of this study were to assess resistance trends for M. catarrhalis, which causes respiratory tract infections, against several classes of oral antibiotics and to compare the minimum inhibitory concentration (MIC) of antimicrobial agents against M. catarrhalis isolates between 1993–1994 and 2001–2004.Methods: Clinical isolates of M. catarrhalis (n = 314) were collected from 11 large medical centers in Taiwan between 2001 and 2004. β-Lactamase production tests were performed. The MICs for 13 different oral antibiotics were calculated using the agar dilution method. Pulsed-field gel electrophoresis (PFGE) was performed for 18 randomly selected high-level ampicillin-resistant (BRO-1 β-lactamase-positive, MIC ≥ 32 μg/mL) isolates to investigate their genetic relatedness.Results: The overall rate of β-lactamase-producing isolates was 97.8% (307/314). All isolates were susceptible to amoxicillin + clavulanate, chloramphenicol, cefixime, ciprofloxacin, erythromycin, levofloxacin, moxifloxacin, and roxithromycin. The rate of resistance to cefaclor and cefuroxime was 8.3% and 1.3%, respectively, while no resistance was found in 1993–1994. Resistance to trimethoprim–sulfamethoxazole (SXT) and tetracycline was 18.5% and 19.8%, respectively. Comparison of 1993–1994 and 2001–2004 isolates revealed that the zone diameter for amoxicillin + clavulanate disks decreased from 43 mm in 1993–1994 to 32 mm in 2001–2004 (p &lt; 0.001). However, MIC50 (0.25 μg/mL in both 1993–1994 and 2001–2004) and MIC90 (0.5 μg/mL in both 1993–1994 and 2001–2004) for amoxicillin + clavulanate did not differ between the study periods. The PFGE typing results demonstrate that at least two closely related BRO-1 clones are spreading in Taiwan.Conclusion: The rates of resistance to cefaclor, cefuroxime, tetracycline and SXT are now increasing in Taiwan. Molecular typing showed that at least two closely related BRO-1 clones are circulating. Although amoxicillin + clavulanate remains the antimicrobial therapy of choice for M. catarrhalis infections, continued surveillance of antimicrobial susceptibility and application of control measures against further transmission are required to inhibit the emergence of the resistant strains.</description><dc:title>Antimicrobial resistance of Moraxella catarrhalis isolates in Taiwan - Corrected Proof</dc:title><dc:creator>Shih-Fen Hsu, Yi-Tsung Lin, Te-Li Chen, L.K. Siu, Po-Ren Hsueh, Shih-Tse Huang, Chang-Phone Fung</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.004</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001629/abstract?rss=yes"><title>Shewanella putrefaciens, a rare cause of splenic abscess - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001629/abstract?rss=yes</link><description>Splenic abscess is uncommon and is still associated with significant morbidity and mortality. Gram-negative bacilli are the most commonly isolated organisms, followed by Gram-positive cocci. However, the predominant organisms found depend on the geographic location. Shewanella putrefaciens is a Gram-negative non-fermentative oxidative bacillus found in the environment. Infection usually manifests with a number of clinical syndromes, most commonly as skin or soft tissue infections, typically in patients whose immune system is compromised. Intra-abdominal abscess is extremely rare. We report a case of a 22-year-old female who presented with S. putrefaciens splenic abscesses as the first manifestation of diabetes mellitus, which was successfully managed with a course of antibiotic therapy.</description><dc:title>Shewanella putrefaciens, a rare cause of splenic abscess - Corrected Proof</dc:title><dc:creator>Norwani Basir, Alice Moi Ling Yong, Vui Heng Chong</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.007</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001654/abstract?rss=yes"><title>Successful treatment of Aerococcus viridans endocarditis in a patient allergic to penicillin - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001654/abstract?rss=yes</link><description>Aerococcus viridans is a rare human pathogen that occasionally causes endocarditis. Most of the reported cases of endocarditis have been treated with penicillin. Here we describe a patient who was allergic to penicillin and was successfully treated with cefotaxime.</description><dc:title>Successful treatment of Aerococcus viridans endocarditis in a patient allergic to penicillin - Corrected Proof</dc:title><dc:creator>Liang-Yu Chen, Wen-Chung Yu, Suang-Hao Huang, Mei-Lin Lin, Te-Li Chen, Chang-Phone Fung, Cheng-Yi Liu</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.010</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS168411821100171X/abstract?rss=yes"><title>Corynebacterium striatum bacteremia associated with central venous catheter infection - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS168411821100171X/abstract?rss=yes</link><description>Corynebacterium striatum (C striatum) has been considered a contaminant of blood culture in past decades. Here we report the case of a patient with acute deterioration of chronic renal failure. She received hemodialysis and died from C striatum bacteremia. By using a randomly amplified polymorphic DNA (RAPD) method, we found that an association existed between C striatum from the bloodstream and that from the central venous catheter. We suggest that C striatum could be a pathogen of bloodstream infection in patients with such a catheter in place.</description><dc:title>Corynebacterium striatum bacteremia associated with central venous catheter infection - Corrected Proof</dc:title><dc:creator>Fu-Lun Chen, Po-Ren Hsueh, Sing-On Teng, Tsong-Yih Ou, Wen-Sen Lee</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.016</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001800/abstract?rss=yes"><title>Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001800/abstract?rss=yes</link><description>Background/Purpose: Enterovirus 71 (EV71) infection may cause severe neurological and cardiopulmonary complications, especially in preschool children. This study is to investigate the seroprevalence and seroconversion of EV71, and the crossprotection of EV71 antibody against other enteroviruses among kindergarteners.Methods: Overall 228 children in a public kindergarten were enrolled during two academic years, 2006 and 2007, in Taipei, Taiwan and we measured their EV71 neutralizing antibody. When the participants had herpangina; hand, foot and mouth disease (HFMD); febrile illness or respiratory symptoms, throat swabs were sampled and processed for viral culture and enterovirus real-time reverse transcriptase polymerase chain reaction (RT-PCR). Questionnaires, completed by the participants’ guardians, surveyed the history of allergy and annual incidence of symptoms related to enterovirus infection.Results: Seropositive rates of EV71 were 20% (32/163) in 2006 and 6% (4/65) in 2007. The rate of EV71 seropositivity increased with age (p &lt; 0.01) in 2006 but it did not differ between genders (p = 0.14). No seroconversion was observed from 2006 to 2007. Herpangina occurred in 64% of children with EV71 seropositivity and 48% of those without EV71 antibodies (p = 0.12). Non-71 enterovirus infection, confirmed by viral study, occurred in 53% (19/36) of the EV71-seropositive children and in 53% (102/192) of EV71-seronegative children (p = 0.89). No participants had EV71 infection during the study period.Conclusion: EV71 did not frequently circulate in Taipei City from September 2006 to June 2008. Presence of EV71 neutralizing antibody was not associated with lower incidence of enterovirus infection caused by non-71 serotypes.</description><dc:title>Seroprevalence of enterovirus 71 and no evidence of crossprotection of enterovirus 71 antibody against the other enteroviruses in kindergarten children in Taipei city - Corrected Proof</dc:title><dc:creator>Wen-Chan Huang, Li-Min Huang, Chuan-Liang Kao, Chun-Yi Lu, Pei-Lan Shao, Ai-Ling Cheng, Tsui-Yien Fan, Hsin Chi, Luan-Yin Chang</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.025</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001812/abstract?rss=yes"><title>Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: A matched case-control study - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001812/abstract?rss=yes</link><description>Background and purpose: Carbapenem-resistant Klebsiella pneumoniae is an emerging problem worldwide. The object of this study was to investigate the risk factors, characteristics and outcomes of ertapenem-nonsusceptible K pneumoniae (ENSKp) bacteremia.Methods: We conducted a 1:2 ratio matched case-control study. The controls were randomly selected among patients with ertapenem-susceptible K pneumoniae (ESKp) bacteremia and were matched with ENSKp cases for bacteremia.Results: Seventy-five patients were included in this study (25 cases and 50 controls). Bivariate analysis showed that prior exposure to either β-Lactam/β-Lactam-lactamase inhibitors (p = 0.008) or 4th generation cephalosporins (p &lt; 0.001), chronic obstructive pulmonary disease (COPD) (p = 0.001), acute renal failure (p = 0.021), chronic kidney disease without dialysis (p = 0.021), recent hospital stay (p = 0.016), intensive care unit stay (p = 0.002), mechanical ventilation (p = 0.003), central venous catheter placement (p = 0.016), Foley indwelling (p = 0.022), polymicrobial bacteremia (p = 0.003) and higher Pittsburgh bacteremia score (p &lt; 0.001) were associated with ENSKp bacteremia. The multivariate analysis showed that prior exposure to 4th generation cephalosporins (odds ratio [OR], 28.05; 95% confidence interval [CI], 2.92–269.85; p = 0.004), COPD (OR, 21.38; 95% CI, 2.95–154.92; p = 0.002) and higher Pittsburgh bacteremia score (OR, 1.35; 95% CI, 1.10–1.66; p = 0.004) were independent factors for ENSKp bacteremia. ENSKp bacteremia had a higher 14-day mortality rate than ESKp bacteremia (44.0% vs. 22.0%; p = 0.049). The overall in-hospital mortality rates for these two groups were 60.0% and 40.0% respectively (p = 0.102).Conclusion: ENSKp bacteremia had a poor outcome and the risk factors were prior exposure of 4th generation cephalosporins, COPD and higher Pittsburgh bacteremia score. Antibiotic stewardship may be the solution for the preventive strategy.</description><dc:title>Outcomes and characteristics of ertapenem-nonsusceptible Klebsiella pneumoniae bacteremia at a university hospital in Northern Taiwan: A matched case-control study - Corrected Proof</dc:title><dc:creator>Shi-Wei Liu, Hong-Jyun Chang, Ju-Hsin Chia, An-Jing Kuo, Tsu-Lan Wu, Ming-Hsun Lee</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.026</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001836/abstract?rss=yes"><title>A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001836/abstract?rss=yes</link><description>Background: Stenotrophomonas maltophilia has emerged as an important opportunistic pathogen in debilitated hosts. Clinical management of S. maltophilia is challenging due to its intrinsic resistance to a variety of antibiotics. This study investigated the trend and prevalence of antimicrobial resistance in S. maltophilia from a nationwide surveillance study in Taiwan.Methods: S. maltophilia isolates were collected biennially between 1998 and 2008 as part of the Taiwan Surveillance of Antimicrobial Resistance (TSAR) program from medical centers and regional hospitals throughout Taiwan. Minimal inhibitory concentrations (MIC) were determined using the Clinical and Laboratory Standards Institute reference broth microdilution method.Results: A total of 377 non-duplicate S. maltophilia isolates were collected from 38 hospitals. The majority of the isolates were from the respiratory tract (256, 67.9%), followed by blood (48, 12.7%). Overall, 376 (99.7%) isolates were susceptible to minocycline, 362 (96%) to tigecycline, 311 (82.5%) to trimethoprim/sulfamethoxazole (TMP-SMX), 300 (79.6%) to levofloxacin, 92 (24.4%) to ceftazidime, and 70 (18.6%) to ticarcillin-clavulanic acid. The MIC50/MIC90 of minocycline, tigecycline, TMP-SMX, levofloxacin, ceftazidime, and ticarcillin-clavulanic acid, were ≤0.5/1μg/mL, 0.25/1μg/mL, ≤0.25/8μg/mL, 1/4μg/mL, 32/128μg/mL, and 64/128μg/mL, respectively. A trend of increased non-susceptibility to levofloxacin (p=0.014) was observed over the 10-year study period. Compared to TMP-SMX-susceptible isolates, TMP-SMX-resistant isolates were less susceptible to levofloxacin (54.5% vs. 84.9%, p&lt;0.001).Conclusion: In this 10-year study, minocycline and TMP-SMX remained the two antimicrobials with better in vitro activities against S. maltophilia than ceftazidime, levofloxacin, and ticarcillin-clavulanic acid. The activity of levofloxacin against S. maltophilia in Taiwan declined during the past 10 years.</description><dc:title>A multicenter surveillance of antimicrobial resistance on Stenotrophomonas maltophilia in Taiwan - Corrected Proof</dc:title><dc:creator>Hsiu Wu, Jen-Tay Wang, Yih-Ru Shiau, Hui-Yin Wang, Tsai-Ling Yang Lauderdale, Shan-Chwen Chang, TSAR Hospitals</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.028</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS168411821100185X/abstract?rss=yes"><title>A review of immunomodulators in the Indian traditional health care system - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS168411821100185X/abstract?rss=yes</link><description>Some of the medicinal plants valued in Ayurvedic Rasayana for their therapeutic potential have been scientifically investigated with promising results. A number of plant-based principles have been isolated with potential immunomodulatory activity that can explain and justify their use in traditional medicine in the past and can form the basis for further research in the future as well. The aim of this review is to highlight results of research done on immunomodulators of plant origin. The selection of papers was made using the most relevant databases for the biomedical sciences on the basis of their ethnopharmacological use. Many plants and some phytoconstituents responsible for immunomodulation have been explained. The review also discusses biological screening methods for various plant drugs that focus on revealing the mechanism involved in immunomodulation. This work shall hopefully encourage researchers to undertake further work on medicinal plants with potential immunomodulatory activity.</description><dc:title>A review of immunomodulators in the Indian traditional health care system - Corrected Proof</dc:title><dc:creator>Dinesh Kumar, Vikrant Arya, Ranjeet Kaur, Zulfiqar Ali Bhat, Vivek Kumar Gupta, Vijender Kumar</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.030</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-12</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-12</prism:publicationDate><prism:section>REVIEW ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001563/abstract?rss=yes"><title>Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001563/abstract?rss=yes</link><description>Background: and purpose: Amino acid substitutions in GyrA and ParC are associated with resistance to quinolones in Acinetobacter baumannii (A baumannii), but this association is rarely elucidated in Acinetobacter genomic species (AGS) 13TU. This study aims to compare the association of amino acid substitutions in GyrA and ParC with quinolone resistance in A baumannii and AGS 13TU in Taiwan.Methods: Eleven representative strains of A baumannii and 13 strains of AGS 13TU were selected from 402 bacteremic isolates. The sequences of quinolone resistance determining regions of gyrA and parC were determined. Minimal inhibitory concentrations (MICs) of nalidixic acid, ciprofloxacin, levofloxacin and moxifloxacin were determined by agar dilution method.Results: Ser83Leu substitution in GyrA in A baumannii (one strain) was associated with resistance to all tested quinolones. This substitution plus a Ser80Leu or Ser80Tyr in ParC in A baumannii (four strains) and AGS 13TU (two strains) were associated with higher MICs of all quinolones. All but one quinolone MICs of A baumannii (one strain) and AGS 13TU (two strains) carrying a single substitution Ser56Asn in ParC remained in the susceptibility breakpoint. The Ser83Leu substitution in GyrA, even with additional Ser56Asn substitution in ParC, was associated with resistance to only nalidixic acid, but not other newer quinolones in AGS 13TU (two strains).Conclusion: A baumannii and AGS 13TU possessed similar quinolone resistance associated with amino acid substitutions in GyrA and ParC. Further study with more strains is needed to determine whether a single Ser83Leu substitution in GyrA was associated with a high level of quinolone MIC only in A baumannii, but not in AGS 13TU.</description><dc:title>Amino acid substitutions of quinolone resistance determining regions in GyrA and ParC associated with quinolone resistance in Acinetobacter baumannii and Acinetobacter genomic species 13TU - Corrected Proof</dc:title><dc:creator>Yen-Hung Liu, Shu-Chen Kuo, Yi-Tzu Lee, Ian C.Y. Chang, Su-Pen Yang, Te-Li Chen, Chang-Phone Fung</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.001</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-08</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-08</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001642/abstract?rss=yes"><title>Japanese viral encephalitis mimicking stroke with an initial manifestation of hemiplegia - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001642/abstract?rss=yes</link><description>Japanese encephalitis (JE) is an endemic disease in Taiwan. After the program to vaccinate children against JE was implemented in 1968, the incidence of JE gradually started to decrease, but it is still an important infectious disease here. Neurological manifestations in JE vary highly during the initial stage of the disease. Focal neurological symptoms, such as hemiplegia, are rarely reported. A 46-year-old male with the initial presentation of abrupt hemiplegia and fever developed mental confusion after 1 day. No bacterial pathogen was isolated from the blood or cerebrospinal fluid (CSF). A diagnosis of JE was confirmed based on the presence of JE virus-specific immunoglobulin M in the CSF and serum samples. It is necessary to consider JE when a patient presents with abrupt hemiplegia with fever followed with mental confusion and seizure, especially if the patient comes from a JE-endemic area.</description><dc:title>Japanese viral encephalitis mimicking stroke with an initial manifestation of hemiplegia - Corrected Proof</dc:title><dc:creator>Huan-Wen Chen, Liang-Wen Ding, Chih-Cheng Lai, Tse-Kai Tseng, Wei-Lun Liu</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.009</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-08</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-08</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS168411821100168X/abstract?rss=yes"><title>Pneumonia due to pandemic (H1N1) 2009 influenza virus and Klebsiella pneumoniae capsular serotype K16 in a patient with nasopharyngeal cancer - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS168411821100168X/abstract?rss=yes</link><description>Streptococcus pneumoniae, Haemophilus influenzae, Staphylococcus aureus and group A Streptoccocus, but no Klebsiella pneumoniae were responsible for bacterial coinfections during the 2009 and previous influenza pandemics. We hereby report a case with concurrent bacteremic pneumonia due to an unusual capsular serotype K16 K. pneumoniae and pandemic (H1N1) 2009 influenza in a patient with nasopharyngeal cancer. Such a coinfection has not previously been described.</description><dc:title>Pneumonia due to pandemic (H1N1) 2009 influenza virus and Klebsiella pneumoniae capsular serotype K16 in a patient with nasopharyngeal cancer - Corrected Proof</dc:title><dc:creator>Chih-Cheng Lai, Pei-Lin Lee, Che-Kim Tan, Yu-Tsung Huang, Chiang-Lian Kao, Jin-Town Wang, Po-Ren Hsueh</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.013</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-08</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-08</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001691/abstract?rss=yes"><title>Rapidly fatal community-acquired pneumonia due to Klebsiella pneumoniae complicated with acute myocarditis and accelerated idioventricular rhythm - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001691/abstract?rss=yes</link><description>We describe a previously healthy 52-year-old man with rapidly fatal community-acquired pneumonia caused by Klebsiella pneumoniae. The patient developed acute renal dysfunction, accelerated idioventricular rhythm (acute myocarditis), lactic acidosis and septic shock. He died within 15 hours after admission despite intravenous levofloxacin (750 mg daily) and aggressive medical treatment.</description><dc:title>Rapidly fatal community-acquired pneumonia due to Klebsiella pneumoniae complicated with acute myocarditis and accelerated idioventricular rhythm - Corrected Proof</dc:title><dc:creator>Tzu-Yi Chuang, Chou-Jui Lin, Shih-Wei Lee, Chun-Pin Chuang, Yuh-Shiun Jong, Wen-Jone Chen, Po-Ren Hsueh</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.014</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-08</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-08</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001708/abstract?rss=yes"><title>Successful treatment of septic shock and respiratory failure due to leptospirosis and scrub typhus coinfection with penicillin, levofloxacin, and activated protein C - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001708/abstract?rss=yes</link><description>Leptospirosis and scrub typhus are common zoonoses and coinfection with both diseases has been reported sporadically, particularly in tropical and subtropical areas. A 53-year-old male presented with acute hypoxemic respiratory failure and septic shock due to leptospirosis and scrub typhus coinfection confirmed by serological assessments. Antibiotics, including intravenous penicillin and levofloxacin, were administered and human recombinant activated protein C was added because of a high risk of death due to septic shock with multiple organ failure. The patient’s hemodynamics and hypoxemia substantially improved 4 days later and he had a complete recovery from the disease after 10 days of hospitalization. Coinfection of leptospirosis and scrub typhus may easily go unrecognized by physicians in febrile travelers or patients in the region where both diseases are endemic. In severe and critical cases of leptospirosis, scrub typhus, or coinfection with both, the use of APC in addition to appropriate antibiotic treatment and standard critical care might provide a greater chance for survival and a favorable outcome.</description><dc:title>Successful treatment of septic shock and respiratory failure due to leptospirosis and scrub typhus coinfection with penicillin, levofloxacin, and activated protein C - Corrected Proof</dc:title><dc:creator>Yu-Feng Wei, Chien-Tung Chiu, Yung-Fa Lai, Chung-Hsu Lai, Hsi-Hsun Lin</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.015</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-08</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-08</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001721/abstract?rss=yes"><title>Epididymo-orchitis: An unusual manifestation of salmonellosis - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001721/abstract?rss=yes</link><description>Salmonellosis continues to be a major public health problem, especially in developing countries. The formation of focal abscesses may occur following either hematogenous or lymphatic spread. There are large number of serious and life-threatening clinical manifestations of Salmonella spp., ranging from osteomyelitis to infective endocarditis and meningitis. However, even though Salmonella epidydimo-orchitis is a relatively rare clinical manifestion, it can present, most often in male babies and adolescent boys, following contact with nontyphoidal Salmonella. Here, we report a case of epididymo-orchitis due to Salmonella Paratyphi A that presented in an otherwise healthy 63-year-old man in order to highlight this organism’s unusual clinical presentation. In countries such as India, where Salmonella infections are endemic, a high index of suspicion should be always be maintained and the possibility of a Salmonella infection at an aberrant site where it is hardly expected should not be ruled out.</description><dc:title>Epididymo-orchitis: An unusual manifestation of salmonellosis - Corrected Proof</dc:title><dc:creator>Neha Bansal, Neelam Kaistha, Jagdish Chander</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.017</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-12-05</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-12-05</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001666/abstract?rss=yes"><title>Staphylococcus lugdunensis endocarditis with isolated tricuspid valve involvement - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001666/abstract?rss=yes</link><description>Staphylococcus lugdunensis is often misidentified as S aureus and as a rare cause of infective endocarditis. The clinical course of S lugdunensis endocarditis is aggressive and the mortality rate is high in contrast to S epidermidis endocarditis. Most reported cases of S lugdunensis endocarditis have involved mitral or aortic valves. Herein, we present a case with isolated tricuspid endocarditis due to S lugdunensis.</description><dc:title>Staphylococcus lugdunensis endocarditis with isolated tricuspid valve involvement - Corrected Proof</dc:title><dc:creator>Kuei-Pin Chung, Hou-Tai Chang, Chun-Hsing Liao, Fang-Yeh Chu, Po-Ren Hsueh</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.011</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-10-31</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-10-31</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001848/abstract?rss=yes"><title>Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001848/abstract?rss=yes</link><description>Background: The purpose of this study is to delineate clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae (ESBL-EK) in different clinical settings, with an emphasis on community-acquired infections.Methods: A retrospective study was conducted at two medical centers in Taiwan. From May 2002 to August 2007, clinical data of adults with urosepsis caused by ESBL-EK were collected. Patients were categorized into three groups according to the place of acquisition. Baseline characteristics, microbiological data and clinical outcomes were compared.Results: Ninety-three cases of ESBL-EK urosepsis were included. Their mean age was 69.4 years, and 48.4% were men. Eleven (11.8%), 41 (44.1%), and 41 (44.1%) patients were categorized as having community-acquired, healthcare-associated, and hospital-acquired infections, respectively. Cases of ESBL-EK urosepsis from different settings shared similar characteristics in terms of age, gender, comorbidity and resistance profiles of bacterial strains. Of the bacterial isolates, 75% and 38.7% were resistant to fluoroquinolones and aminoglycosides, respectively. Cases of community-acquired urosepsis had a lower disease severity than those acquired in healthcare facilities or hospitals. Of note, there was no case fatality in 11 cases of community-acquired urosepsis and, in contrast, a crude mortality rate of 41.5% was found among adults with hospital-acquired urosepsis (p &lt; 0.001).Conclusion: A limited number of adults with community-acquired urosepsis caused by ESBL-EK in the present study had a favorable outcome. Nonetheless, clinicians should be cautious of the emergence of urinary tract infections caused by ESBL-producers in the community setting.</description><dc:title>Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community - Corrected Proof</dc:title><dc:creator>Jen-Chieh Lee, Nan-Yao Lee, Hsin-Chun Lee, Wei-Han Huang, Ko-Chung Tsui, Chia-Ming Chang, Ching-Chi Lee, Po-Lin Chen, Chi-Jung Wu, Po-Ren Hsueh, Wen-Chien Ko</dc:creator><dc:identifier>10.1016/j.jmii.2011.09.029</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-10-31</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-10-31</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211001368/abstract?rss=yes"><title>Corrigendum to “Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India” [J Microbiol Immunol Infect 2011;44:166–71] - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211001368/abstract?rss=yes</link><description>The author regrets for the incorrect author and affiliation published in this article. The correct order of the authors is as follows:   Ali Abdul Lattifa,∗, Gauranga Mukhopadhyayb, Uma Banerjeec, Ravinder Goswamic and Rajendra Prasadb</description><dc:title>Corrigendum to “Molecular typing and in vitro fluconazole susceptibility of Candida species isolated from diabetic and nondiabetic women with vulvovaginal candidiasis in India” [J Microbiol Immunol Infect 2011;44:166–71] - Corrected Proof</dc:title><dc:creator>Ali Abdul Lattif</dc:creator><dc:identifier>10.1016/j.jmii.2011.05.001</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-06-03</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-06-03</prism:publicationDate></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000028/abstract?rss=yes"><title>Corrigendum to “Changing cytokine patterns in systemic lupus: a prospective longitudinal study” [JMicrobiolImmunolInfect 2010;43:18–25] - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000028/abstract?rss=yes</link><description>The article published in this journal with the code [2010;43(1):18–25] and the name “Changing cytokine patterns in systemic lupus: a prospective longitudinal study” (authored by Lieh-Bang Liou and Wan-Ju Chao) has misplaced “This research was approved by the Medical Ethics Committee of Chang Gung Memorial Hospital, Taoyuan County, Taiwan.” in the Ethics approval section (the first sentence) of Methods section. Actually, the National Science Council of the Republic of China, Taiwan had not enforced the requirement of a research grant acquiring confirmation from an institutional review board in that year. Hence, the proposal of this published article had not been sent to the Medical Ethics Committee of Chang Gung Memorial Hospital, Taoyuan County, Taiwan. Therefore, the first sentence “This research was approved by the Medical Ethics Committee of Chang Gung Memorial Hospital, Taoyuan County, Taiwan.” of Ethics approval in Methods section of this published article has to be retracted from this article.</description><dc:title>Corrigendum to “Changing cytokine patterns in systemic lupus: a prospective longitudinal study” [JMicrobiolImmunolInfect 2010;43:18–25] - Corrected Proof</dc:title><dc:creator>Lieh-Bang Liou, Wan-Ju Chao</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.001</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>CORRIGENDUM</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS168411821100003X/abstract?rss=yes"><title>Human colostral phagocytes eliminate enterotoxigenic Escherichia coli opsonized by colostrum supernatant - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS168411821100003X/abstract?rss=yes</link><description>Background: Several elements in colostrum and human milk, including antibodies and nonspecific factors with bactericidal and antiviral activity, may play an important anti-infectious and protective role. In developing countries, enterotoxigenic Escherichia coli (ETEC) is the main etiological agent of diarrhea in low-socioeconomic level children. In the present work, we studied the functional activity of mononuclear (MN) and polymorphonuclear (PMN) phagocytes of human colostrum against ETEC, as well as the interactions between these cells and colostral or serum opsonins.Methods: Colostrum samples were collected from 33 clinically healthy women between 48 and 72 hours postpartum. We verified superoxide release in colostral MN and PMN using cytochrome C reduction methods, phagocytosis, and bactericidal activity using acridine orange methods and superoxide dismutase (SOD) in the colostrum supernatants.Results: Colostral MN and PMN phagocytes exposed to ETEC opsonized with colostrum supernatants caused a significant increase (p&lt;0.05) in superoxide release. Phagocytosis by colostral PMN cells increased significantly (p&lt;0.5) when the phagocytes were incubated with both sources of opsonins (sera and colostrum). Increases in superoxide release in the presence of opsonized bacteria triggered the bactericidal activity of the phagocytes. Phagocyte treatment with SOD decreased their ability to eliminate ETEC. Colostrum supernatant had higher SOD concentrations (p&lt;0.05) compared with normal human sera.Conclusions: These results suggest that the ability of phagocytes to eliminate ETEC depends on the activation of cellular oxidative metabolism; moreover, activation of colostral phagocytes is likely an additional breast-feeding protection mechanism against intestinal infections in infants.</description><dc:title>Human colostral phagocytes eliminate enterotoxigenic Escherichia coli opsonized by colostrum supernatant - Corrected Proof</dc:title><dc:creator>Eduardo Luzía França, Renata Vieira Bitencourt, Mahmi Fujimori, Tassiane Cristina de Morais, Iracema de Mattos Paranhos Calderon, Adenilda Cristina Honorio-França</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.002</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000041/abstract?rss=yes"><title>Serotypes, surface proteins, and clinical syndromes of invasive Group B streptococcal infections in northern Taiwan, 1998–2009 - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000041/abstract?rss=yes</link><description>Background: The incidence of invasive Group B streptococcal (GBS) infections is increasing in the elderly and immunocompromised adults in many countries worldwide. There are, however, few reports regarding the current status of the infection in northern Taiwan. This study investigated retrospectively the molecular epidemiology and clinical syndromes of the invasive GBS diseases in a tertiary care hospital in northern Taiwan over the past decade.Methods: One hundred twenty episodes of invasive GBS disease were recorded at Cathay General Hospital, a tertiary care, teaching hospital in northern Taiwan, from January 1998 to June 2009. Clinical information was acquired from medical records. Capsular serotypes and alpha family of surface proteins were genotyped with multiplex and specific polymerase chain reaction.Results: Of all episodes, 58.3% was found in the elderly (age≥65), 36.1% in nonpregnant women and young adults (age 18–64), and 5.9% in the neonates (0–90 days). Case-fatality rate was 6.7%. Eighty-three (69%) of the invasive isolates were available for genotyping. In sharp contrast to the studies in southern Taiwan (1991–2004), Type Ib (26.5%) was the most frequent invasive isolate, followed by V (22.9%), III (18.1%), VI (12%), Ia (10.8%), II (6%), VIII (2.4%), and nontypable strain (1.2%). In particular, Serotype VI, which had been rarely implicated in invasive infection, emerged as a significant pathogen. A significant trend of increase in incidence was observed for the infection (p&lt;0.0001), with concurrent increase of cases in the elderly and of Serotype Ib and VI. There was significant association with young adults of Type II and III and chronic skin conditions and older adults with Type Ia and V and chronic cardiovascular diseases. Type V was closely associated with skin and soft tissue infection. Recurrent episodes (10%) occurred most often in patients with concomitant malignancy, with an average of 314 days for recurrence.Conclusions: The incidence of GBS invasive infection among nonpregnant women and adults is rising in northern Taiwan, particularly in the elderly caused by Serotype Ib and VI. Population-based surveillance program should be implanted for assessment of the disease burden to the susceptible adult population.</description><dc:title>Serotypes, surface proteins, and clinical syndromes of invasive Group B streptococcal infections in northern Taiwan, 1998–2009 - Corrected Proof</dc:title><dc:creator>Swee Siang Wong, Kochung Tsui, Qin-Dong Liu, Li-Chen Lin, Chim Ren Tsai, Li-Chun Chen, Cheng Hua Huang</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.003</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000053/abstract?rss=yes"><title>Isolation of Campylobacter sp in surface waters of Taiwan - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000053/abstract?rss=yes</link><description>Background: Campylobacter sp is one of the main causes of human acute enteritis and diarrhea. It is commonly found in bird intestinal canal and pollutes water bodies through bird droppings. Clinically, detection of Campylobacter sp is by culture method and most are fecal samples. The objective of this study is to investigate the distribution of Campylobacter sp in river water of Taiwan.Methods: The detection of campylobacters in water by the U.K. Health Protection Agency was adopted and simplified. Water samples (1L) were enriched through membrane filters and selective enrichment Bolton broth. The mCCDA medium was used for culturing Campylobacter sp. In addition to using the selective media, DNA sequencing for species’ identification was also included in this study.Results: Campylobacter sp was detected in only 2 of 75 water samples, and 72 suspected strains were isolated from the selective mCCDA medium, in which several pathogenic bacteria included Escherichia coli O157.Conclusions: Not only there was pollution of Campylobacter sp in water environment but also other antibiotics-resistant pathogenic bacteria, which may cause public health risk.</description><dc:title>Isolation of Campylobacter sp in surface waters of Taiwan - Corrected Proof</dc:title><dc:creator>Tai-Lee Hu, Pao-chi Kuo</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.004</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000065/abstract?rss=yes"><title>Detection of immunoglobulin G antibodies to Toxoplasma gondii: Evaluation of two commercial immunoassay systems - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000065/abstract?rss=yes</link><description>Background: Toxoplasmosis is a disease, which can cause severe congenital infection and is normally diagnosed by the detection of Toxoplasma gondii (T gondii)-specific antibodies in the serum of infected patients. Several different tests allow to distinguish recent from past infections and to quantify anti-T gondii-specific IgG, and the results can be used as markers for a chronic or recently seroconverted toxoplasma.Methods: In the present study, the recent Cobas 6000 Toxo IgG assay (Roche Diagnostics, Indianapolis, IN, USA) for the serological diagnosis of toxoplasmosis was compared with the Axsym Toxo IgG assay (Abbott Laboratories, Diagnostics Division, Abbott Park, IL, USA) employing a panel of negative, low- or high-reactive serum samples that were selected after routine screening in a laboratory of clinical analyses.Results: The overall agreement between two methods was 99% (r=0.99, p&lt;0.001). Of 91 analyzed samples, only one presented discrepant result, being positive in the Cobas 6000 Toxo IgG assay and negative in the Axsym Toxo IgG assay. By using an immunofluorescent assay as a confirmation test, this positive result was assayed to be negative.Conclusions: The both assays performed in each analyzer were proven to be fast and fully automated procedures for reproducible measurement of IgG antibodies to T gondii. The new method, used for the determination of anti-T gondii IgG antibodies, should be evaluated with a further analysis with increased number of serum samples to get a broad performance of this newer test.</description><dc:title>Detection of immunoglobulin G antibodies to Toxoplasma gondii: Evaluation of two commercial immunoassay systems - Corrected Proof</dc:title><dc:creator>Nilgun Tekkesin, Kenan Keskin, Cumhur Kılınc, Nuray Orgen, Kaya Molo</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.005</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000077/abstract?rss=yes"><title>Molecular and phenotypic characterization of atypical enteropathogenic Escherichia coli serotypes isolated from children with and without diarrhea - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000077/abstract?rss=yes</link><description>Background: We characterized 36 atypical enteropathogenic Escherichia coli (EPEC) serotypes isolated from children with and without diarrhea in Iran. Because the identification of atypical EPEC based on biochemical features is rather difficult and time consuming, we used a combination of three approaches, including a polymerase chain reaction-based method, culture adherence assay, and the restriction analysis of fliC gene (fliC-restriction fragment length polymorphism), to identify E coli serotypes.Methods: To distinguish typical and atypical EPEC strains, the presence of EPEC attaching effacing A gene (eaeA) gene and EPEC-attaching factor (EAF) plasmid were analyzed. All E coli strains were identified based on the detection of the eaeA+, bundle-forming pili A gene (bfpA−), EAF− or eaeA−, bfpA+, EAF− profiles and the absence of stx (encoded for shiga toxin) gene as atypical EPEC.Results: All strains studied, belonged to 5 atypical EPEC serogroups and 15 serotypes based on the virulence profiles. Of 36 atypical EPEC serotypes, 22 (61.2%) and 14 (38.8%) strains isolated from diarrheal and healthy cases, respectively. O142:H48 (19.5%) and O111:H21 (11.1%) serotypes were the most prevalent isolates, followed by serotypes O111: H− and O86:H48 (5.6% each).Conclusions: The characteristics of the atypical EPEC serotypes from children with diarrhea were significantly different from those of in children without diarrhea. The compilation of data on atypical EPEC strains presented here indicates the importance of a combined approach of conventional and molecular tests to study the virulence and epidemiology of EPEC serotypes in human subjects.</description><dc:title>Molecular and phenotypic characterization of atypical enteropathogenic Escherichia coli serotypes isolated from children with and without diarrhea - Corrected Proof</dc:title><dc:creator>Mohammad Mehdi Aslani, Mohammad Yousef Alikhani</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.006</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000089/abstract?rss=yes"><title>Intravenous minocycline versus oral doxycycline for the treatment of noncomplicated scrub typhus - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000089/abstract?rss=yes</link><description>Background: Scrub typhus is an acute febrile disease for which synthetic tetracycline antibiotics are efficacious. However, no clinical studies have compared oral doxycycline with intravenous minocycline for treatment of scrub typhus.Methods: We conducted a retrospective analysis in patients diagnosed with noncomplicated scrub typhus by serologic or molecular methods from August 2001 to July 2007. We compared the efficacy of intravenous minocycline with oral doxycycline for treatment of noncomplicated scrub typhus in these patients.Results: Forty seven cases receiving tetracycline antibiotics for the treatment of noncomplicated scrub typhus were included. There was no statistically significant difference for the response rate between the 25 cases receiving intravenous minocycline (96%) and the 22 cases receiving oral doxycycline (91%) (p=0.909). Kaplan-Meier curve with a long-rank test for the time to defervescence showed no statistically significant difference between minocycline therapy (mean 30 hours; range 4–124 hours) and doxycycline therapy (mean 32.4 hours; range 4–144 hours) (p=0.860). After multivariate Cox regression models, the time to defervescence was only affected by Acute Physiology and Chronic Health Evaluation II score (hazard ratio 0.868; p=0.016). Nearly all patients (93.6%) became afebrile within 72 hours after use of tetracycline antibiotics. Prolonged hospitalization (&gt;7 days) was correlated with the timing to start tetracycline antibiotics after admission.Conclusion: Both antibiotics have similar efficacy for the treatment of noncomplicated scrub typhus. Nearly all cases responding to both antibiotics became afebrile within 3 days.</description><dc:title>Intravenous minocycline versus oral doxycycline for the treatment of noncomplicated scrub typhus - Corrected Proof</dc:title><dc:creator>Chen-Chi Tsai, Chorng-Jang Lay, Yu-Huai Ho, Lih-Shinn Wang, Li-Kuang Chen</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.007</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000090/abstract?rss=yes"><title>Emergence and dissemination of blaOXA-23-carrying imipenem-resistant Acinetobacter sp in a regional hospital in Taiwan - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000090/abstract?rss=yes</link><description>Background: The distribution and characterization of OXA-type carbapenemases in Acinetobacter sp in Taiwan has less been reported. The aim of the study was to investigate the molecular epidemiology and OXA-type carbapenemase genes in a regional hospital in Taiwan.Methods: Imipenem-resistant Acinetobacter sp were collected between 2005 and 2007 in a regional hospital. Genotyping was performed by pulsed-field gel electrophoresis. OXA-type carbapenemase genes were determined by multiplex PCR and gene sequencing.Results: A total of 136 isolates were collected. Fifty-six pulsotypes were identified. None of the pulsotypes established predominance throughout the 3-year period. Multiplex PCR of blaOXA genes showed that 99% (135/136) of the Acinetobacter sp possessed blaOXA51-like genes. The coexistences of blaOXA51-like/blaOXA-23-like and blaOXA51-like/blaOXA-24-like were detected in 19% (26/136) and 1% (2/136) of the isolates, respectively. Among blaOXA-23-like gene-carrying isolates, two isolates (Pulsotypes 18 and 20) were found in 2006 and the remainder (n=24), including Pulsotypes 27 (n=18), 29 (n=1), 52 (n=3), and 53 (n=2), were found in 2007. Sequencing performed on the 26 representative isolates confirmed the presence of the blaOXA-23 carbapenemase gene. Analysis of the genetic content of blaOXA-23 showed that these genes were presumably chromosomal and associated with the upstream-located insertion sequence ISAba1.Conclusions: The emergence and imminent widespread of blaOXA-23-carrying imipenem-resistant Acinetobacter sp appeared in Taiwan during the period from 2006 to 2007.</description><dc:title>Emergence and dissemination of blaOXA-23-carrying imipenem-resistant Acinetobacter sp in a regional hospital in Taiwan - Corrected Proof</dc:title><dc:creator>Ming-Feng Lin, Han-Yueh Kuo, Hui-Wen Yeh, Chih-Man Yang, Chih-Hung Sung, Chi-Chao Tu, Mei-Luan Huang, Ming-Li Liou</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.008</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000119/abstract?rss=yes"><title>Etanercept treatment for children with refractory juvenile idiopathic arthritis - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000119/abstract?rss=yes</link><description>Background: Etanercept has been shown to be an effective treatment for juvenile idiopathic arthritis (JIA). In this study, we evaluated the effectiveness of etanercept therapy in the treatment of refractory JIA.Methods: This was a retrospective analysis of 11 patients with refractory JIA (polyarticular type n=7; pauciarticular type, n=2; systemic type, n=2) who received treatment with etanercept during the period 2005–2009 in a medical center. The indications for etanercept treatment included persistent fever, arthritis/arthralgia, or elevated levels of inflammatory mediators after treatment with methotrexate and/or prednisolone for more than 6 months. The patients were treated with etanercept (0.4mg/kg, with maximal 25mg, subcutaneously, twice a week) for a total of 12 months.Results: The degree of arthritis/arthralgia improved (range of motion and painful sensation of involved joints), and the levels of inflammatory markers (C-reactive protein and erythrocyte sedimentation rate) decreased progressively in 10 of the 11 patients (p&lt;0.05) at 1-, 3-, 5-, and 12-month follow-up after treatment with etanercept. Mean hemoglobin levels significantly increased, whereas mean platelet counts decreased after etanercept treatment (p&lt;0.05). Only one patient with systemic type of JIA failed to respond to the treatment after 6 weeks of etanercept therapy. Methotrexate, prednisolone, and other immunosuppressive drugs were successfully discontinued after a mean of 2.5 months (range, 1–5 months) of etanercept therapy in the 10 patients who responded to etanercept treatment.Conclusion: Etanercept is beneficial for patients with polyarticular and pauciarticular type of JIA that is refractory to conventional treatment but less beneficial for systemic type of JIA.</description><dc:title>Etanercept treatment for children with refractory juvenile idiopathic arthritis - Corrected Proof</dc:title><dc:creator>Ho-Chang Kuo, Hong-Ren Yu, Chih-Chiang Wu, Ling-Sai Chang, Kuender D. Yang</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.010</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000120/abstract?rss=yes"><title>Determination of antimicrobial susceptibility patterns and inducible clindamycin resistance in Staphylococcus aureus strains recovered from southeastern Turkey - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000120/abstract?rss=yes</link><description>Background: In this study, we determined the susceptibility patterns of Staphylococcus aureus strains to various antimicrobials and prevalence of inducible clindamycin resistance (ICR) in these isolates.Methods: Two hundred one S aureus strains, isolated from various clinical samples, were included in the study. Antibiotic susceptibilities were studied by disc diffusion method on the basis of the guidelines by the Clinical and Laboratory Standards Institute. The disc diffusion induction test (D test) was applied to determine ICR resistance among erythromycin-resistant S aureus isolates.Results: Of 201 S aureus strains, 101 (50.2%) were resistant to methicillin. All strains were susceptible to vancomycin, teicoplanin, quinupristin/dalfopristin, and linezolid. It was found that 54 (53.4%) methicillin-resistant S aureus (MRSA) strains were erythromycin resistant, and 40 (39.6%) of them showed constitutive clindamycin resistance. ICR was detected in seven (6.9%) MRSA strains. It was found that 13 (13.0%) methicillin-susceptible S aureus (MSSA) strains were erythromycin resistant. Constitutive clindamycin resistance was seen in one (1.0%) MSSA strain, and ICR was detected in 10 (10.0%) cases.Conclusion: There was a high rate of methicillin resistance among S aureus strains in our hospital. However, no statistically significant difference of ICR was observed between MRSA and MSSA strains (p=0.434) or between inpatients and outpatients (p=0.804). It was concluded that ICR should be routinely evaluated in each S aureus case to avoid therapy failure among patients.</description><dc:title>Determination of antimicrobial susceptibility patterns and inducible clindamycin resistance in Staphylococcus aureus strains recovered from southeastern Turkey - Corrected Proof</dc:title><dc:creator>Fahriye Eksi, Efgan Dogan Gayyurhan, Aysen Bayram, Tekin Karsligil</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.011</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000132/abstract?rss=yes"><title>Clinical significance of erythromycin-resistant Campylobacter jejuni in children - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000132/abstract?rss=yes</link><description>Campylobacter has been recognized as the common cause of bacterial gastroenteritis in many countries. Increasing erythromycin resistance in Campylobacter jejuni infection is noted recently, but severe case was rarely reported. In this study, we aimed to clarify the clinical significance of the resistant strain of C jejuni in children. We reviewed the charts of children who were diagnosed with C jejuni enteritis in our hospital from January 2000 to December 2005, including 326 patients (117 males and 209 females). All the cases had positive stool culture. We divided them into two groups, the sensitive group (a total of 306 cases) and resistant group (a total of 20 cases), according to the drug sensitivity. We analyzed the clinical manifestations and laboratory data between the two groups. The mean age was 3.79±3.24 years in the sensitive group and 3.03±2.84 years in the resistant group. There was no significant difference between the two groups in clinical presentations and laboratory examinations. No mortality was found, and one case was initially presented with colonic perforation. This report demonstrates that infection by erythromycin-resistant strains of C jejuni has no clinical significance in children, despite the probably increased emergence of erythromycin resistance.</description><dc:title>Clinical significance of erythromycin-resistant Campylobacter jejuni in children - Corrected Proof</dc:title><dc:creator>Sheng-Ming Wang, Fu-Chen Huang, Chi-Hung Wu, Kuo-Shu Tang, Mao-Meng Tiao</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.012</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>BRIEF COMMUNICATION</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000144/abstract?rss=yes"><title>Comamonas testosteroni infection in Taiwan: Reported two cases and literature review - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000144/abstract?rss=yes</link><description>Comamonas testosteroni is a widely distributed aerobic gram-negative bacillus. Infection by C testosteroni is infrequent, and no such cases have been reported in Taiwan. Here, we would like to present a 54-year-old alcoholic patient from Taiwan, and his left leg was injured during a fishing trip, resulting in left leg cellulitis and C testosteroni bacteremia. The patient’s fever subsided after initial treatment with extended-spectrum cephalosporin, whereas his erythematous swelling did not resolve until switched to ciprofloxacin. The second patient is a 73-year-old Taiwanese male with chronic hepatitis B infection, liver cirrhosis, and hepatocellular carcinoma. Comamonas testosteroni bacteremia was found after transarterial embolization. Further studies are necessary to determine the best antibiotic(s) for patients infected with C testosteroni.</description><dc:title>Comamonas testosteroni infection in Taiwan: Reported two cases and literature review - Corrected Proof</dc:title><dc:creator>Tung-Lin Tsui, Shih-Ming Tsao, Ken-Sen Liu, Tzy-Yen Chen, Ya-Lin Wang, Ying-Hock Teng, Yuan-Ti Lee</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.013</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000156/abstract?rss=yes"><title>Visceral leishmaniasis (kala-azar) and malaria coinfection in an immigrant in the state of Terengganu, Malaysia: A case report - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000156/abstract?rss=yes</link><description>Malaria is endemic in Malaysia. Leishmaniasis is a protozoan infection rarely reported in Malaysia. Here, a 24-year-old Nepalese man who presented with prolonged fever and hepatosplenomegaly is reported. Blood film examination confirmed a Plasmodium vivax malaria infection. Despite being adequately treated for malaria, his fever persisted. Bone marrow examination showed presence of Leishman-Donovan complex. He was successfully treated with prolonged course of amphotericin B. The case highlights the importance of awareness among the treating physicians of this disease occurring in a foreign national from an endemic region when he presents with fever and hepatosplenomegaly. Coinfection with malaria can occur although it is rare. It can cause significant delay of the diagnosis of leishmaniasis.</description><dc:title>Visceral leishmaniasis (kala-azar) and malaria coinfection in an immigrant in the state of Terengganu, Malaysia: A case report - Corrected Proof</dc:title><dc:creator>Ahmad Kashfi Ab Rahman, Fatimah Haslina Abdullah</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.014</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-23</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-23</prism:publicationDate><prism:section>CASE REPORT</prism:section></item><item rdf:about="http://www.e-jmii.com/article/PIIS1684118211000107/abstract?rss=yes"><title>Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients - Corrected Proof</title><link>http://www.e-jmii.com/article/PIIS1684118211000107/abstract?rss=yes</link><description>Background: Tigecycline was approved for the treatment of complicated intra-abdominal and complicated skin/skin structure infections. Because of its in vitro effectiveness for multidrug-resistant (MDR) isolates, tigecycline has been prescribed more broadly. This study evaluated tigecycline use after its first introduction in Taiwan and experience with tigecycline for the treatment of MDR Acinetobacter baumannii (MDRAB) infection, especially for ventilator-associated pneumonia.Methods: Patients treated with tigecycline were collected retrospectively from February 2008 to July 2008 in Taipei Veterans General Hospital, a 2900-bed tertiary care medical center in Taiwan. Patients were divided into one of three groups according to the indications: Group 1, Food and Drug Administration–approved indications; Group 2, health care–associated pneumonia (HAP); and Group 3, urinary tract infection, osteomyelitis, bacteremia, etc. Cases of MDRAB were also identified.Results: Among 66 cases, indications for the administration of tigecycline included Food and Drug Administration–approved indications (12, 18.2%), HAP (38, 57.6%), bacteremia (3, 4.5%), catheter-related infections (3, 4.5%), urinary tract infection (4, 6.1%), osteomyelitis (4, 6.1%), and others (2, 3%). Clinical outcome was positive in 20 cases, with higher clinical success rate for Group 1 than Group 2, which may correlate with higher Sequential Organ Failure Assessment score, older age, and more frequent intensive care admission in Group 2. Of the microbiologically evaluable cases, MDRAB predominated (33/51, 64.7%). Among infections with MDRAB (excluding pneumonia without ventilator), the clinical success rate was 12% (3/25).Conclusions: The most common indication for the prescription of tigecycline was HAP. Success rate for MDRAB infection was lower than that previously reported, possibly because of serious underlying conditions and comorbidities in our patients. Because of limited choices, physicians should weigh the risk and benefit for prescribing tigecycline.</description><dc:title>Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients - Corrected Proof</dc:title><dc:creator>Shu-Chen Kuo, Fu-Der Wang, Chang-Phone Fung, Liang-Yu Chen, Su-Jung Chen, Mei-Chun Chiang, Shih-Fen Hsu, Cheng-Yi Liu</dc:creator><dc:identifier>10.1016/j.jmii.2011.01.009</dc:identifier><dc:source>Journal of Microbiology, Immunology and Infection (2011)</dc:source><dc:date>2011-03-16</dc:date><prism:publicationName>Journal of Microbiology, Immunology and Infection</prism:publicationName><prism:publicationDate>2011-03-16</prism:publicationDate><prism:section>ORIGINAL ARTICLE</prism:section></item></rdf:RDF>
